CD277 agonist enhances the immunogenicity of relapsed/refractory acute myeloid leukemia towards Vδ2+ T cell cytotoxicity
Author:
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00277-022-04930-8.pdf
Reference30 articles.
1. Pollyea DA, Bixby D, Perl A et al (2021) NCCN guidelines insights: acute myeloid leukemia, version 2.2021. J Natl Compr Canc Netw 19(1):16–27. https://doi.org/10.6004/jnccn.2021.0002
2. Thol F, Ganser A (2020) Treatment of relapsed acute myeloid leukemia. Curr Treat Options Oncol 21(8):66. https://doi.org/10.1007/s11864-020-00765-5
3. Döhner H, Weisdorf DJ, Bloomfield CD (2015) Acute myeloid leukemia. N Engl J Med 373(12):1136–1152. https://doi.org/10.1056/NEJMra1406184
4. Rashidi A, Weisdorf DJ, Bejanyan N (2018) Treatment of relapsed/refractory acute myeloid leukaemia in adults. Br J Haematol 181(1):27–37. https://doi.org/10.1111/bjh.15077
5. Heinicke T, Krahl R, Kahl C et al (2021) Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials. Ann Hematol 100(9):2387–2398. https://doi.org/10.1007/s00277-021-04565-1
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Delta One T cells recognize AML via DNAM-1;Blood;2024-04-11
2. Landscape of unconventional γδ T cell subsets in cancer;Molecular Biology Reports;2024-01-30
3. γδ T cells as immunotherapy for malaria: balancing challenges and opportunities;Frontiers in Immunology;2023-12-06
4. Recent advance in phytonanomedicine and mineral nanomedicine delivery system of the treatment for acute myeloid leukemia;Journal of Nanobiotechnology;2023-07-26
5. Improved Vδ2+ T cells recovery correlates to reduced incidences of mortality and relapse in acute myeloid leukemia after hematopoietic transplantation;Annals of Hematology;2023-02-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3